AU1557000A - Insulin production by engineered muscle cells - Google Patents

Insulin production by engineered muscle cells

Info

Publication number: AU1557000A
Authority: AU; Australia
Prior art keywords: muscle cells; insulin production; engineered muscle; engineered; insulin
Prior art date: 1998-11-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU15570/00A

Inventor

Fatima Bosch

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Universitat Autonoma de Barcelona UAB

Original Assignee

Universitat Autonoma de Barcelona UAB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-20

Filing date

1999-11-19

Publication date

2000-06-13

1999-11-19 Application filed by Universitat Autonoma de Barcelona UAB filed Critical Universitat Autonoma de Barcelona UAB

2000-06-13 Publication of AU1557000A publication Critical patent/AU1557000A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biotechnology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Wood Science & Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AU15570/00A 1998-11-20 1999-11-19 Insulin production by engineered muscle cells Abandoned AU1557000A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10918198P	1998-11-20	1998-11-20
US60109181		1998-11-20
PCT/EP1999/009132 WO2000031267A1 (en)	1998-11-20	1999-11-19	Insulin production by engineered muscle cells

Publications (1)

Publication Number	Publication Date
AU1557000A true AU1557000A (en)	2000-06-13

Family

ID=22326242

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU15570/00A Abandoned AU1557000A (en)	1998-11-20	1999-11-19	Insulin production by engineered muscle cells

Country Status (2)

Country	Link
AU (1)	AU1557000A (en)
WO (1)	WO2000031267A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2170720B1 (en) *	2000-12-20	2003-12-16	Univ Barcelona Autonoma	JOINT USE OF THE INSULIN GENE AND THE GLUCOQUINASE GENE IN THE DEVELOPMENT OF THERAPEUTIC APPROXIMATIONS FOR MELLITUS DIABETES.
WO2003059253A2 (en) *	2001-12-21	2003-07-24	Smithkline Beecham Corporation	Compositions and methods for altering glucose production
NO338606B1 (en) *	2002-06-18	2016-09-12	Eisai R&D Man Co Ltd	A pharmaceutical composition comprising primary cultured pre-adipocytes that stably maintains a foreign gene encoding lecithin-cholesterol acyltransferase (LCAT); the primary cultured pre-adipocytes for use in gene therapy; an in vitro method of preparing them; an implant composition comprising them and a non-human animal implanted with them.
HUE025872T2 (en) *	2002-06-18	2016-05-30	Eisai R&D Man Co Ltd	Primary cultured adipocytes for gene therapy
JP4879867B2 (en) *	2002-06-18	2012-02-22	エーザイ・アール・アンド・ディー・マネジメント株式会社	Primary cultured adipocytes for gene therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL102785A (en) *	1991-08-20	1998-06-15	Univ Leicester	Method for removing protein from a water- soluble gum and a method of making biocompatible capsules using said gum
AU5390696A (en) *	1995-04-20	1996-11-07	University Of South Florida	Purified and isolated sertoli cell aggregate
US5962313A (en) *	1996-01-18	1999-10-05	Avigen, Inc.	Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
AU737129B2 (en) *	1996-08-23	2001-08-09	Arch Development Corporation	Long-term expression of gene products by transforming muscle cells

1999
- 1999-11-19 AU AU15570/00A patent/AU1557000A/en not_active Abandoned
- 1999-11-19 WO PCT/EP1999/009132 patent/WO2000031267A1/en active Application Filing

Also Published As

Publication number	Publication date
WO2000031267A1 (en)	2000-06-02

Publication	Publication Date	Title
PL351202A1 (en)	2003-03-24	Thienopyrimidine compounds, their production and use
AU1241101A (en)	2001-05-08	Cyanide detoxification process
AU5833701A (en)	2001-10-30	Improved electrolytic cell
AU5728200A (en)	2001-01-02	Polycarbonate production method
AU4145499A (en)	1999-12-30	Novel insulin analogs with enhanced zinc binding
AU1557000A (en)	2000-06-13	Insulin production by engineered muscle cells
EP0988857B8 (en)	2006-05-03	Nutrient infusion preparation
AU6474700A (en)	2001-03-13	Electrode structure, electric component and production methods
AU7318700A (en)	2001-04-24	Novel transaldolase gene
AU6006800A (en)	2001-02-05	Treating cells
AU2626599A (en)	1999-09-15	Production cell
AUPP696798A0 (en)	1998-12-03	Improved reactor
AU2003213791A1 (en)	2003-09-22	Multiplexed cell transfection using coded carriers
AU6726098A (en)	1998-09-18	Creatine-ascorbates, production process
AU2001244628A1 (en)	2002-02-05	Pyroligneous acid
AU4498600A (en)	2000-11-17	Distributed manufacturing with feedback
GB2343678B (en)	2002-12-11	Agglomerate production
AUPQ228399A0 (en)	1999-09-09	Production plant
AU5550700A (en)	2001-01-09	Novel process
AU4961400A (en)	2001-05-10	Anode
AU5086400A (en)	2000-12-12	Improved retroviral production
AU5404600A (en)	2001-01-31	Method for producing 4,6-dichloropyrimidine with acid chlorides
AU5521800A (en)	2001-01-22	Novel process
AU5995900A (en)	2001-01-30	Novel process
AU3467100A (en)	2000-09-28	Method for producing cathodic nickel

Legal Events

Date	Code	Title	Description
2001-08-16	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase